Comparing the Rate of Insufficient Cells for Diagnosis Between Surepath® and Conventional Smear in Women After Radiation Therapy for Cervical Cancer

NCT01988376 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

258

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DEVICE: Surepath
DEVICE: Conventional Pap smear

Sponsor

Far Eastern Memorial Hospital

Collaborators

[object Object]